Company: VCYT
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001384101-25-000051
Chunk: 56

Company: VERACYTE, INC.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 56
---
000 |                  |     | 675,000 |                  |     | 3.8 |          |
| Rebecca Chambers |     | 510,000 |                  |     | 530,400 |                  |     | 4.0 |          |
| Phillip Febbo(1) |     | 550,000 |                  |     | 550,000 |                  |     | 0.0 |          |
| John Leite(2)    |     | 450,000 |                  |     | 472,500 |                  |     | 5.0 |          |
| Annie McGuire(3) |     | 440,000 |                  |     | 470,800 |                  |     | 7.0 |          |

(1) Dr. Febbo was hired as Chief Scientific and Chief Medical Officer effective October 2, 2023. His salary for 2024 was approved in connection with his appointment.

(2) Dr. Leite was promoted from Senior Vice President, General Manager, Pulmonology & Market Access to Chief Commercial Officer, CLIA effective September 1, 2023. Dr. Leite’s salary was increased to $450,000 in connection to his promotion.

(3) Ms. McGuire assumed oversight of the project management office effective January 2024. Ms. McGuire’s salary increase is reflective of the role expansion and annual salary review.

#### 2024 Annual Cash Incentives
We provide our executives, including our NEOs, with the opportunity to annually earn cash incentives to encourage the achievement of corporate objectives, and to reward those individuals who significantly impact our corporate results. Payments under our annual bonus plan are based on the achievement of corporate goals established by our Board of Directors. Actual performance against these metrics funds the annual bonus plan pool and threshold levels of performance must be met for the pool to be funded.

Each of our NEOs participated in our 2024 annual bonus plan. Executive officers who participate in this plan have an established annual incentive target, which is equal to a percentage of their base salary. The actual earned annual incentive bonus, if any, is calculated based on the bonus plan pool funding, pre-established company performance metrics and any adjustments for individual performance as assessed by the Compensation Committee (taking into consideration the assessment by the Chief Executive Officer) for the NEOs, and by the Board of Directors for the Chief Executive Officer. For 2024, our NEOs had the annual bonus target opportunities set forth in